SCHEMBL30001005

SCHEMBL30001005

Cc1cc(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)n(C)n1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MMP13 P45452 1/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 4/20 0.45
FFAR1 O14842 1/20 0.43
MCL1 Q07820 2/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.39
BCL2 P10415 1/20 0.39
SORD Q00796 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
RORC P51449 3/20 0.38
MCOLN3 Q8TDD5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19635340 0.78 MEN1 (0.45) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL24744626 0.76 MEN1 (0.62) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL21802224 0.75 MCL1 (0.45) MEN1KMT2ASMN1; SMN2L3MBTL1MMP13
SCHEMBL19615367 0.75 MEN1 (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL19615199 0.73 MCL1 (0.41) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL21802226 0.73 MCL1 (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
Acetic Acid SCHEMBL28656086 0.73 MCL1 (0.46) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL28656085 0.71 MCL1 (0.42) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL19615186 0.71 MEN1 (0.66) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL14924450 0.70 MEN1 (0.73) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255888-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed